Aleksandra H. S.
- Country
- Poland
- Department
- N/A
Research Overview
- Phase 2/3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in Participants with Agitation in Alzheimer’s Disease
- Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Chronic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
- Efficacy and Safety Evaluation of Clostridium Botulinum Neurotoxin Type A in Episodic Migraine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 51 of 121 partner sites.
Specializations
Sleep Medicine
The investigator specializes in the study and treatment of insomnia disorder, conducting clinical research to evaluate innovative therapeutic approaches for sleep disturbances.
- Sleep Disorders
- Sleep-Wake Pattern Disorders
- Sleep Medicine Therapeutics
Research activities center on evaluating novel pharmacological interventions for improving sleep quality and addressing chronic insomnia conditions.
Neurological Disorders
Focus on investigating sleep-related neurological conditions and their impact on patient well-being, with particular attention to therapeutic management strategies.
- Sleep-Related Neural Mechanisms
- Neuropharmacology
- Clinical Neuroscience
Expertise includes assessment of neural pathways involved in sleep regulation and their therapeutic modulation.
Clinical Therapeutics
Engaged in evaluating novel therapeutic compounds for sleep disorders, with emphasis on understanding their efficacy and clinical applications.
- Drug Development
- Clinical Assessment
- Treatment Outcomes
Research encompasses the evaluation of innovative therapeutic approaches for sleep disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.